Literature DB >> 25587903

Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.

Pimonrat Ketsawatsomkron1, Curt D Sigmund.   

Abstract

PURPOSE OF REVIEW: This review summarizes recent findings on the regulation of vascular tone by the nuclear receptor transcription factor, peroxisome proliferator activated receptor (PPAR) γ. Much of the recent work utilizes genetic tools to interrogate the significance of PPARγ in endothelial and smooth muscle cells and novel PPARγ target genes have been identified. RECENT
FINDINGS: Endothelial PPARγ prevents inflammation and oxidative stress, while promoting vasodilation by controlling the regulation of NADPH oxidase, catalase and superoxide dismutase gene expression. Moreover, the protective functions of endothelial PPARγ appear more prominent during disease conditions. Novel findings also suggest a role for endothelial PPARγ as a mediator of whole body metabolism. In smooth muscle cells, PPARγ regulates vascular tone by targeting genes involved with contraction and relaxation signaling cascades, some of which is via transcriptional activation, and some through novel mechanisms regulating protein turnover. Furthermore, aberrant changes in renin-angiotensin system components and exacerbated responses to angiotensin II induced vascular dysfunction are observed when PPARγ function is lost in smooth muscle cells.
SUMMARY: With these recent advances based partially on lessons from patients with PPARγ mutants, we conclude that vascular PPARγ is protective and plays an important role in the regulation of vascular tone.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25587903      PMCID: PMC4384504          DOI: 10.1097/MNH.0000000000000103

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  49 in total

1.  A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.

Authors:  Gabriel Pascual; Amy L Fong; Sumito Ogawa; Amir Gamliel; Andrew C Li; Valentina Perissi; David W Rose; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Nature       Date:  2005-08-28       Impact factor: 49.962

2.  Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.

Authors:  Chiara Marchesi; Asia Rehman; Yohann Rautureau; Daniel A Kasal; Marie Briet; Avshalom Leibowitz; Stefania M C Simeone; Talin Ebrahimian; Mario F Neves; Stefan Offermanns; Frank J Gonzalez; Pierre Paradis; Ernesto L Schiffrin
Journal:  Cardiovasc Res       Date:  2012-12-17       Impact factor: 10.787

3.  A clinical link between peroxisome proliferator-activated receptor γ and the renin-angiotensin system.

Authors:  Curt D Sigmund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04       Impact factor: 8.311

4.  KLF11 mediates PPARγ cerebrovascular protection in ischaemic stroke.

Authors:  Ke-Jie Yin; Yanbo Fan; Milton Hamblin; Jifeng Zhang; Tainqing Zhu; Siming Li; John R Hawse; Malayannan Subramaniam; Chao-Zhong Song; Raul Urrutia; Jiandie D Lin; Y Eugene Chen
Journal:  Brain       Date:  2013-02-12       Impact factor: 13.501

5.  Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.

Authors:  Martine Auclair; Corinne Vigouroux; Franck Boccara; Emilie Capel; Catherine Vigeral; Bruno Guerci; Olivier Lascols; Jacqueline Capeau; Martine Caron-Debarle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-07       Impact factor: 8.311

6.  Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk.

Authors:  Yihong Wan; Alan Saghatelian; Ling-Wa Chong; Chun-Li Zhang; Benjamin F Cravatt; Ronald M Evans
Journal:  Genes Dev       Date:  2007-07-24       Impact factor: 11.361

7.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

Review 8.  Effects of thiazolidinediones on blood pressure.

Authors:  Thomas D Giles; Gary E Sander
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

9.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

10.  Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.

Authors:  Kosaku Goto; Tatsuya Iso; Hirofumi Hanaoka; Aiko Yamaguchi; Toshihiro Suga; Akinari Hattori; Yasunori Irie; Yuji Shinagawa; Hiroki Matsui; Mas Rizky A A Syamsunarno; Miki Matsui; Anwarul Haque; Masashi Arai; Fumio Kunimoto; Tomoyuki Yokoyama; Keigo Endo; Frank J Gonzalez; Masahiko Kurabayashi
Journal:  J Am Heart Assoc       Date:  2013-01-18       Impact factor: 5.501

View more
  11 in total

Review 1.  PPARγ Regulation in Hypertension and Metabolic Syndrome.

Authors:  Madeliene Stump; Masashi Mukohda; Chunyan Hu; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

2.  Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.

Authors:  Pimonrat Ketsawatsomkron; Henry L Keen; Deborah R Davis; Ko-Ting Lu; Madeliene Stump; T Michael De Silva; Aline M Hilzendeger; Justin L Grobe; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

3.  Vascular Matrix Metalloproteinase Inhibition, a New Mechanism for How Peroxisome Proliferator-Activated Receptor-γ Protects Target Organ Damage.

Authors:  Steven J Forrester; Satoru Eguchi
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

4.  Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress.

Authors:  Masashi Mukohda; Madeliene Stump; Pimonrat Ketsawatsomkron; Chunyan Hu; Frederick W Quelle; Curt D Sigmund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-13       Impact factor: 4.733

5.  Peroxisome proliferator-activated receptor gamma blunts endothelin-1-mediated contraction of the uterine artery in a murine model of high-altitude pregnancy.

Authors:  Sydney L Lane; Alexandrea S Doyle; Elise S Bales; Julie A Houck; Ramón A Lorca; Lorna G Moore; Colleen G Julian
Journal:  FASEB J       Date:  2020-01-23       Impact factor: 5.191

6.  Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway.

Authors:  Ching-Han Lin; Shang-Yu Lee; Chun-Cheng Zhang; Ye-Fong Du; Hao-Chang Hung; Hung-Tsung Wu; Horng-Yih Ou
Journal:  Drug Des Devel Ther       Date:  2016-11-01       Impact factor: 4.162

7.  BIRC5 is a novel target of peroxisome proliferator‑activated receptor γ in brain microvascular endothelium cells during cerebral ischemia.

Authors:  Mingjing Xu; Xianli Yang; Qing Zeng; He He; Pengcheng Lu; Guozhi Huang
Journal:  Mol Med Rep       Date:  2017-10-10       Impact factor: 2.952

8.  The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells.

Authors:  Rongzhong Huang; Zicheng Hu; Yuxing Feng; Lehua Yu; Xingsheng Li
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

Review 9.  PPARγ and Its Role in Cardiovascular Diseases.

Authors:  Mini Chandra; Sumitra Miriyala; Manikandan Panchatcharam
Journal:  PPAR Res       Date:  2017-01-24       Impact factor: 4.964

Review 10.  Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones.

Authors:  D Alemán-González-Duhart; F Tamay-Cach; S Álvarez-Almazán; J E Mendieta-Wejebe
Journal:  PPAR Res       Date:  2016-05-23       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.